Abstract
Depression is a prevalent and devastating neuropsychiatric illness that causes great socioeconomic burden. One of the most challenging aspects in studying and treating depression is the subjective nature of this illness. For centuries, scholars and philosophers have pondered over the causes of depression. We have now developed a multilayered approach to define, understand, and treat depression. In what follows, we will highlight the current conceptual trends in the neurobiology of depression and point to new directions in treatment approaches.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Hirschfeld RM. American health care systems and depression: the past, present, and the future. J Clin Psychiatry. 1998;59 Suppl 20:5–10.
Greden JF. The burden of recurrent depression: causes, consequences, and future prospects. J Clin Psychiatry. 2001;62 Suppl 22:5–9.
Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet. 1997;349(9063):1436–42.
Greenberg PE, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64(12):1465–75.
Fava M, Davidson KG. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin N Am. 1996;19(2):179–200.
Petersen T, et al. Treatment resistant depression and axis I co-morbidity. Psychol Med. 2001;31(7):1223–9.
Corey-Lisle PK, et al. Identification of a claims data “signature” and economic consequences for treatment-resistant depression. J Clin Psychiatry. 2002;63(8):717–26.
Kessler RC, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095–105.
Klerman GL, Weissman MM. Increasing rates of depression. JAMA. 1989;261(15):2229–35.
Robins LN, Regier DA. Psychiatric disorders in America: the epidemiological catchment area study. New York: The Free Press; 1991.
Trivedi MH, et al. Clinical results for patients with major depressive disorder in the Texas Medication Algorithm Project. Arch Gen Psychiatry. 2004;61(7):669–80.
Khan A, et al. Placebo response and antidepressant clinical trial outcome. J Nerv Ment Dis. 2003;191(4):211–8.
Keller MB. Long-term treatment of recurrent and chronic depression. J Clin Psychiatry. 2001;62 Suppl 24:3–5.
Williams N, et al. Relapse rates with long-term antidepressant drug therapy: a meta-analysis. Hum Psychopharmacol. 2009;24(5):401–8.
Kupfer DJ. Long-term treatment of depression. J Clin Psychiatry. 1991;52(Suppl):28–34.
Kendler KS, Thornton LM, Gardner CO. Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the “kindling” hypothesis. Am J Psychiatry. 2000;157(8):1243–51.
Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psychiatry. 2001;62 Suppl 16:10–7.
Caspi A, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301(5631):386–9.
Kendler KS, Thornton LM, Prescott CA. Gender differences in the rates of exposure to stressful life events and sensitivity to their depressogenic effects. Am J Psychiatry. 2001;158(4):587–93.
Post RM. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neurosci Biobehav Rev. 2007;31:858–73.
Solomon DA, et al. Multiple recurrences of major depressive disorder. Am J Psychiatry. 2000;157(2):229–33.
Anisman H, Merali Z. Cytokines, stress, and depressive illness. Brain Behav Immun. 2002;16(5):513–24.
Paykel ES. Life events and affective disorders. Acta Psychiatr Scand Suppl. 2003;418:61–6.
Charney DS. Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. Am J Psychiatry. 2004;161(2):195–216.
Drevets WC, Bogers W, Raichle ME. Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. Eur Neuropsychopharmacol. 2002;12(6):527–44.
Sheline YI. 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity. Biol Psychiatry. 2000;48(8):791–800.
Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 1998;95(22):13290–5.
Drevets WC, Ongur D, Price JL. Reduced glucose metabolism in the subgenual prefrontal cortex in unipolar depression. Mol Psychiatry. 1998;3(3):190–1.
Steingard RJ, et al. Smaller frontal lobe white matter volumes in depressed adolescents. Biol Psychiatry. 2002;52(5):413–7.
Damasio AR, et al. Subcortical and cortical brain activity during the feeling of self-generated emotions. Nat Neurosci. 2000;3(10):1049–56.
Panksepp J. At the interface of the affective, behavioral, and cognitive neurosciences: decoding the emotional feelings of the brain. Brain Cogn. 2003;52(1):4–14.
Elliott R, et al. The neural basis of mood-congruent processing biases in depression. Arch Gen Psychiatry. 2002;59(7):597–604.
Davidson RJ, et al. Neural and behavioral substrates of mood and mood regulation. Biol Psychiatry. 2002;52(6):478–502.
Murphy TH, et al. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron. 1989;2(6):1547–58.
Sapolsky RM, Pulsinelli WA. Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science. 1985;229:1397–400.
Cerqueira JJ, et al. The prefrontal cortex as a key target of the maladaptive response to stress. J Neurosci. 2007;27(11):2781–7.
Sackeim HA, Prohovnik I. Brain imaging studies of depressive disorders. In: Mann JJ, Kupfer DJ, editors. The biology of depressive disorders. New York: Plenum; 1993.
Mayberg HS, et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry. 2000;48(8):830–43.
Shirayama Y, et al. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci. 2002;22(8):3251–61.
Li R, El-Mallahk RS. A novel evidence of different mechanisms of lithium and valproate neuroprotective action on human SY5Y neuroblastoma cells: caspase-3 dependency. Neurosci Lett. 2000;294(3):147–50.
Chen AC, et al. Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect. Biol Psychiatry. 2001;49(9):753–62.
Lucassen PJ, et al. Chronic psychosocial stress differentially affects apoptosis in hippocampal subregions and cortex of the adult tree shrew. Eur J Neurosci. 2001;14(1):161–6.
Manji HK, Duman RS. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull. 2001;35(2):5–49.
Nahon E, et al. Fluoxetine (Prozac) interaction with the mitochondrial voltage-dependent anion channel and protection against apoptotic cell death. FEBS Lett. 2005;579(22):5105–10.
Chiou SH, et al. Moclobemide upregulated Bcl-2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular-regulated kinase pathway. Br J Pharmacol. 2006;148(5):587–98.
Cole PM, Martin SE, Dennis TA. Emotion regulation as a scientific construct: methodological challenges and directions for child development research. Child Dev. 2004;75(2):317–33.
Pessoa L. On the relationship between emotion and cognition. Nat Rev Neurosci. 2008;9(2):148–58.
Southam-Gerow MA, Kendall PC, Weersing VR. Examining outcome variability: correlates of treatment response in a child and adolescent anxiety clinic. J Clin Child Psychol. 2001;30(3):422–36.
Cole PM, Michel MK, Teti LO. The development of emotion regulation and dysregulation: a clinical perspective. Monogr Soc Res Child Dev. 1994;59(2–3):73–100.
Davidson RJ. The functional neuroanatomy of affective style. In: Lane RD, Nadel L, editors. Cognitive neuroscience of emotion. New York: Oxford University Press; 2000. p. 371–88.
Lyubomirsky S, Caldwell ND, Nolen-Hoeksema S. Effects of ruminative and distracting responses to depressed mood on retrieval of autobiographical memories. J Pers Soc Psychol. 1998;75(1):166–77.
Siegle GJ, et al. Increased amygdala and decreased dorsolateral prefrontal BOLD responses in unipolar depression: related and independent features. Biol Psychiatry. 2007;61(2):198–209.
Siegle GJ, et al. Can’t shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals. Biol Psychiatry. 2002;51(9):693–707.
Schimmack U, Derryberry D. Attentional interference effects of emotional pictures: threat, negativity, or arousal? Emotion. 2005;5(1):55–66.
Verbruggen F, De Houwer J. Do emotional stimuli interfere with response inhibition? Evidence from the stop signal paradigm. Cogn Emot. 2007;21(2):391–403.
Hartikainen KM, Ogawa KH, Knight RT. Transient interference of right hemispheric function due to automatic emotional processing. Neuropsychologia. 2000;38(12):1576–80.
Mitchell DG, et al. Emotion at the expense of cognition: psychopathic individuals outperform controls on an operant response task. J Abnorm Psychol. 2006;115(3):559–66.
Ottowitz WE, Dougherty DD, Savage CR. The neural network basis for abnormalities of attention and executive function in major depressive disorder: implications for application of the medical disease model to psychiatric disorders. Harv Rev Psychiatry. 2002;10(2):86–99.
Gross JJ. Antecedent- and response-focused emotion regulation: divergent consequences for experience, expression, and physiology. J Pers Soc Psychol. 1998;74(1):224–37.
Gross JJ. Emotion regulation: affective, cognitive, and social consequences. Psychophysiology. 2002;39(3):281–91.
Ochsner KN, et al. Rethinking feelings: an FMRI study of the cognitive regulation of emotion. J Cogn Neurosci. 2002;14(8):1215–29.
Hajcak G, Nieuwenhuis S. Reappraisal modulates the electrocortical response to negative pictures. Cogn Affect Behav Neurosci. 2006;6(4):291–7.
Ochsner KN, Gross JJ. The cognitive control of emotion. Trends Cogn Sci. 2005;9(5):242–9.
Beauregard M, Levesque J, Bourgouin P. Neural correlates of conscious self-regulation of emotion. J Neurosci. 2001;21(18):RC165.
Levesque J, et al. Neural circuitry underlying voluntary suppression of sadness. Biol Psychiatry. 2003;53(6):502–10.
Phan KL, et al. Neural substrates for voluntary suppression of negative affect: a functional magnetic resonance imaging study. Biol Psychiatry. 2005;57(3):210–9.
Eippert F, et al. Regulation of emotional responses elicited by threat-related stimuli. Hum Brain Mapp. 2007;28(5):409–23.
Urry HL, et al. Amygdala and ventromedial prefrontal cortex are inversely coupled during regulation of negative affect and predict the diurnal pattern of cortisol secretion among older adults. J Neurosci. 2006;26(16):4415–25.
Ochsner KN, et al. For better or for worse: neural systems supporting the cognitive down- and up-regulation of negative emotion. Neuroimage. 2004;23(2):483–99.
Broca P. Anatomie comparee des circonvolutions cerebrales. Le grand lobe limbique et la scissure limbique dans la serie des mammiferes. Rev Anthropol. 1878;1:456–98.
Papez JW. A proposed mechanism of emotion. Arch Neurol Psychiatry. 1937;38:725–43.
Maclean PD, editor. The triune brain in evolution: role in paleocerebral functions. New York: Plenum Press; 1990. 672 pp.
Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci. 1986;9:357–81.
Mega MS, Cummings JL. Frontal subcortical circuits and neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci. 1994;6:358–70.
Abercrombie HC, et al. Metabolic rate in the right amygdala predicts negative affect in depressed patients. Neuroreport. 1998;9(14):3301–7.
Milak MS, et al. Neuroanatomic correlates of psychopathologic components of major depressive disorder. Arch Gen Psychiatry. 2005;62(4):397–408.
Graff-Guerrero A, et al. Frontal and limbic metabolic differences in subjects selected according to genetic variation of the SLC6A4 gene polymorphism. Neuroimage. 2005;25(4):1197–204.
Mayberg HS, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry. 1999;156(5):675–82.
Jacobs B, et al. Regional dendritic and spine variation in human cerebral cortex: a quantitative golgi study. Cereb Cortex. 2001;11(6):558–71.
Petrides M, Pandya D. Efferent association pathways from the rostral prefrontal cortex in the macaque monkey. J Neurosci. 2007;27(43):11573–86.
Goldman-Rakic PS. Topography of cognition: parallel distributed networks in primate association cortex. Annu Rev Neurosci. 1988;11:137–56.
Ramnani N, Owen A. Anterior prefrontal cortex: insights into function from anatomy and neuroimaging. Nat Rev Neurosci. 2004;5(3):184–94.
Posner MI, et al. Localization of cognitive operations in the human brain. Science. 1988;240:1627–31.
Kjaer TW, et al. Increased dopamine tone during meditation-induced change of consciousness. Brain Res Cogn Brain Res. 2002;13(2):255–9.
Vogeley K, et al. Mind reading: neural mechanisms of theory of mind and self-perspective. Neuroimage. 2001;14(1 Pt 1):170–81.
Raichle ME, Snyder AZ. A default mode of brain function: a brief history of an evolving idea. Neuroimage. 2007;37(4):1083–9.
Greicius MD, et al. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry. 2007;62(5):429–37.
Petrides M. Lateral prefrontal cortex: architectonic and functional organization. Philos Trans R Soc Lond Ser B Biol Sci. 2005;360(1456):781–95.
Rush AJ, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006;163(11):1905–17.
Fava GA. Can long-term treatment with antidepressant drugs worsen the course of depression? J Clin Psychiatry. 2003;64(2):123–33.
Baldessarini RJ, Ghaemi SN, Viguera AC. Tolerance in antidepressant treatment. Psychother Psychosom. 2002;71(4):177–9.
Felder R, Rousseau R. Elemental principles of chemical processes. New York: Wiley; 2005.
Davidson RJ, et al. Depression: perspectives from affective neuroscience. Annu Rev Psychol. 2002;53:545–74.
Nestler EJ, et al. Preclinical models: status of basic research in depression. Biol Psychiatry. 2002;52(6):503–28.
Kellner CH, et al. Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). Arch Gen Psychiatry. 2006;63(12):1337–44.
Sackeim HA, et al. The cognitive effects of electroconvulsive therapy in community settings. Neuropsychopharmacology. 2007;32(1):244–54.
Sackeim HA, et al. The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome (see comments). Arch Gen Psychiatry. 1996;53(9):814–24.
George MS, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010;67(5):507–16.
O’Reardon JP, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007;62:1208–16.
Nahas Z, et al. Brain effects of TMS delivered over prefrontal cortex in depressed adults: role of stimulation frequency and coil-cortex distance. J Neuropsychiatry Clin Neurosci. 2001;13(4):459–70.
Nahas Z, et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry. 2005;66(9):1097–104.
Nahas Z, et al. Serial vagus nerve stimulation functional MRI in treatment-resistant depression. Neuropsychopharmacology. 2007;32(8):1649–60.
Deep-Brain Stimulation for Parkinson’s Disease Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson’s disease. N Engl J Med. 2001;345(13):956–63.
Lozano AM, et al. Globus pallidus internus pallidotomy for generalized dystonia. Mov Disord. 1997;12(6):865–70.
Pool JL. Psychosurgery of older people. J Geriatr Assoc. 1954;2:456–65.
Mark VH, et al. The destruction of both anterior thalamic nuclei in a patient with intractable agitated depression. J Nerv Ment Dis. 1970;150(4):266–72.
Lozano AM, et al. Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry. 2008;64(6):461–7.
Malone Jr D, et al. Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry. 2009;65(4):267–75.
Schlaepfer TE, et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology. 2008;33(2):368–77.
Nahas Z, et al. Bilateral epidural prefrontal cortical stimulation for treatment-resistant depression. Biol Psychiatry. 2010;67(2):101–9.
Kopell BH, et al. Epidural cortical stimulation of the left dorsolateral prefrontal cortex for refractory major depressive disorder. Neurosurgery. 2011;69(5):1015–29. discussion 1029.
Herbsman T, et al. More lateral and anterior prefrontal coil location is associated with better repetitive transcranial magnetic stimulation antidepressant response. Biol Psychiatry. 2009;66(5):509–15.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this chapter
Cite this chapter
Nahas, Z. (2016). Depression: Current Conceptual Trends. In: Camprodon, J., Rauch, S., Greenberg, B., Dougherty, D. (eds) Psychiatric Neurotherapeutics. Current Clinical Psychiatry. Humana Press, New York, NY. https://doi.org/10.1007/978-1-59745-495-7_1
Download citation
DOI: https://doi.org/10.1007/978-1-59745-495-7_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-934115-50-3
Online ISBN: 978-1-59745-495-7
eBook Packages: MedicineMedicine (R0)